Vor Biopharma (VOR) Other Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Other Non-Current Assets data on file, last reported at $2.4 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 1.65% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1.65% YoY) and the FY2025 annual result came in at $2.4 million, changed 0.04% from the prior year.
• Other Non-Current Assets climbed to $2.4 million in Q1 2026 per VOR's latest filing, from $2.4 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $8.2 million in Q1 2022 and bottomed at $269000.0 in Q3 2025.
• The 5-year median for Other Non-Current Assets is $2.8 million (2023), against an average of $3.1 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets jumped 217.16%; it then tumbled 89.29% in 2025.
• Tracing VOR's Other Non-Current Assets over 5 years: stood at $2.9 million in 2022, then surged by 64.51% to $4.8 million in 2023, then slumped by 50.48% to $2.4 million in 2024, then grew by 0.04% to $2.4 million in 2025, then advanced by 1.01% to $2.4 million in 2026.
• Per Business Quant, the three latest VOR Other Non-Current Assets figures stand at $2.4 million (Q1 2026), $2.4 million (Q4 2025), and $269000.0 (Q3 2025).

Peer Comparison